Oxalic Acid

Oxalic Acid

SCHEMBL9048417

COc1ccc2[nH]cc(C3CCN(CCc4cnn(C)c4)CC3)c2c1.O=C(O)C(=O)O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 12/20 0.55
HTR1A P08908 11/20 0.55
DRD2 P14416 6/20 0.53
HTR7 P34969 6/20 0.53
HTR6 P50406 6/20 0.53
HTR2A P28223 5/20 0.53
MTNR1A P48039 1/20 0.52
MTNR1B P49286 1/20 0.52
CCR2 P41597 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL9046836 0.91 SLC6A4 (0.51) SLC6A4HTR1ADRD2HTR7HTR6
Oxalic Acid SCHEMBL9049150 0.90 SLC6A4 (0.51) SLC6A4HTR1ADRD2HTR7HTR6
Oxalic Acid SCHEMBL9030775 0.89 SLC6A4 (0.60) SLC6A4HTR1ADRD2HTR7HTR6
Oxalic Acid SCHEMBL9048375 0.88 MAPT (0.56) HTR1ADRD2HTR7HTR6HTR2A
Oxalic Acid SCHEMBL9045241 0.88 HTR1D (0.44) HTR1ADRD2CCR2
SCHEMBL7455861 0.85 SLC6A4 (0.53) SLC6A4HTR1ADRD2HTR7HTR6
SCHEMBL7459744 0.85 SLC6A4 (0.54) SLC6A4HTR1ADRD2HTR7HTR6
SCHEMBL7461070 0.84 OPRM1 (0.48) SLC6A4HTR1ADRD2HTR7HTR6
Hydrochloric Acid SCHEMBL9031667 0.82 SLC6A4 (0.61) SLC6A4HTR1ADRD2HTR7HTR6
Oxalic Acid SCHEMBL7859768 0.82 OPRM1 (0.48) SLC6A4DRD2HTR7HTR2ACCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0708102-A1 5-HT1F agonists for the treatment of migraine ELI LILLY AND COMPANY (US) 1996-04-24 EP disclosed